These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 9760820

  • 1. [Evaluation of the rate for reaching steady state during oral propafenone therapy in patients with ventricular arrhythmias].
    Dabrowski R, Skrabucha B, Kunicki PK, Kowalik I, Skorykow-Sapińska A, Sitkiewicz D, Sadowski Z.
    Pol Arch Med Wewn; 1998 Apr; 99(4):323-30. PubMed ID: 9760820
    [Abstract] [Full Text] [Related]

  • 2. [Evaluation of antiarrhythmic efficacy of sotalol in various doses in patients with ventricular tachyarrhythmias].
    Luczak D, Dabrowski R, Szwed H, Gasior Z, Stanke A, Jasek S, Skrabucha B, Matar A, Kowalik I.
    Pol Merkur Lekarski; 1997 Feb; 2(8):122-5. PubMed ID: 9538657
    [Abstract] [Full Text] [Related]

  • 3. The influence of CYP2D6 polymorphism on the antiarrhythmic efficacy of propafenone in patients with paroxysmal atrial fibrillation during 3 months propafenone prophylactic treatment.
    Jazwinska-Tarnawska E, Orzechowska-Juzwenko K, Niewinski P, Rzemislawska Z, Loboz-Grudzien K, Dmochowska-Perz M, Slawin J.
    Int J Clin Pharmacol Ther; 2001 Jul; 39(7):288-92. PubMed ID: 11471772
    [Abstract] [Full Text] [Related]

  • 4. [Cibenzoline versus propafenone by the oral route for preventing recurrence of atrial arrhythmia: multicenter, randomized, double-blind study].
    Lardoux H, Maison Blanche P, Marchand X, Canler A, Rouesnel P, Bleinc D, Péraudeau P, Scheck F.
    Ann Cardiol Angeiol (Paris); 1996 Oct; 45(8):469-79. PubMed ID: 8952741
    [Abstract] [Full Text] [Related]

  • 5. Effect of CYP2D6*10 genotype on propafenone pharmacodynamics in Chinese patients with ventricular arrhythmia.
    Cai WM, Xu J, Chen B, Zhang FM, Huang YZ, Zhang YD.
    Acta Pharmacol Sin; 2002 Nov; 23(11):1040-4. PubMed ID: 12421483
    [Abstract] [Full Text] [Related]

  • 6. [Propafenone and flecainide in the therapy of ventricular arrhythmias].
    Paperini L, Davini A, Lattanzi F, Topi A, Reisenhofer B, Squarcini G, Paci A, Topi PL.
    Minerva Cardioangiol; 1995 Oct; 43(10):449-57. PubMed ID: 8819814
    [Abstract] [Full Text] [Related]

  • 7. Antiarrhythmic efficacy and tolerance of oral propafenone in patients with frequent ventricular arrhythmias: experience of a multicentre study.
    Geibel A, Meinertz T, Zehender M, Vitak J, Hohnloser S, Kunz-Fritze A, Just H.
    Eur Heart J; 1989 Sep; 10 Suppl E():81-7. PubMed ID: 2680506
    [Abstract] [Full Text] [Related]

  • 8. Antiarrhythmic efficacy of propafenone: evaluation of effective plasma levels following single and multiple doses.
    Frabetti L, Marchesini B, Capucci A, Cavallini C, Gubelli S, Ambrosioni E, Magnani B.
    Eur J Clin Pharmacol; 1986 Sep; 30(6):665-71. PubMed ID: 2429844
    [Abstract] [Full Text] [Related]

  • 9. Usefulness of propafenone for supraventricular arrhythmias in infants and children.
    Janousek J, Paul T, Reimer A, Kallfelz HC.
    Am J Cardiol; 1993 Aug 01; 72(3):294-300. PubMed ID: 8342507
    [Abstract] [Full Text] [Related]

  • 10. Short-term and long-term treatment with propafenone: determinants of arrhythmia suppression, persistence of efficacy, arrhythmogenesis, and side effects in patients with symptoms.
    Zehender M, Hohnloser S, Geibel A, Furtwängler A, Olschewski M, Meinertz T, Just H.
    Br Heart J; 1992 Jun 01; 67(6):491-7. PubMed ID: 1622701
    [Abstract] [Full Text] [Related]

  • 11. Propafenone shows class Ic and class II antiarrhythmic effects.
    Stoschitzky K, Stoschitzky G, Lercher P, Brussee H, Lamprecht G, Lindner W.
    Europace; 2016 Apr 01; 18(4):568-71. PubMed ID: 26056191
    [Abstract] [Full Text] [Related]

  • 12. Effect of CYP2D6 polymorphisms on the pharmacokinetics of propafenone and its two main metabolites.
    Rouini MR, Afshar M.
    Therapie; 2017 Jun 01; 72(3):373-382. PubMed ID: 28087064
    [Abstract] [Full Text] [Related]

  • 13. Clinical pharmacology of propafenone.
    Connolly SJ, Kates RE, Lebsack CS, Harrison DC, Winkle RA.
    Circulation; 1983 Sep 01; 68(3):589-96. PubMed ID: 6872170
    [Abstract] [Full Text] [Related]

  • 14. Sustained therapeutic efficacy and safety of oral propafenone for treatment of chronic ventricular arrhythmias: a 2-year experience.
    Dinh H, Baker BJ, de Soyza N, Murphy ML.
    Am Heart J; 1988 Jan 01; 115(1 Pt 1):92-6. PubMed ID: 3336989
    [Abstract] [Full Text] [Related]

  • 15. Effects of propafenone on ventricular arrhythmias: double-blind, parallel, randomized, placebo-controlled dose-ranging study.
    Singh BN, Kaplinsky E, Kirsten E, Guerrero J.
    Am Heart J; 1988 Dec 01; 116(6 Pt 1):1542-51. PubMed ID: 3057844
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetic and pharmacodynamic evaluation of propafenone in patients with ventricular arrhythmia. Propafenone Research Group.
    Zoble RG, Kirsten EB, Brewington J.
    Clin Pharmacol Ther; 1989 May 01; 45(5):535-41. PubMed ID: 2721109
    [Abstract] [Full Text] [Related]

  • 17. [Diprafenone--comparative study of anti-arrhythmia therapy with propafenone].
    Geibel A, Zehender M, Hohnloser S, Landsrath C, Meinertz T, Just H.
    Z Kardiol; 1988 Jul 01; 77(7):464-9. PubMed ID: 2463720
    [Abstract] [Full Text] [Related]

  • 18. [Amiodarone and propafenone: evaluation using serial Holter recordings in patients with ventricular arrhythmia].
    Ventosa A, Adragão P, Bonhorst D, Seabra-Gomes R.
    Rev Port Cardiol; 1990 Jan 01; 9(1):33-9. PubMed ID: 1691653
    [Abstract] [Full Text] [Related]

  • 19. Antiarrhythmic efficacy of penticainide and comparison with disopyramide, flecainide, propafenone and mexiletine by acute oral drug testing.
    Priori SG, Bonazzi O, Facchini M, Varisco T, Schwartz PJ.
    Am J Cardiol; 1987 Nov 01; 60(13):1068-72. PubMed ID: 3118693
    [Abstract] [Full Text] [Related]

  • 20. Ibutilide added to propafenone for the conversion of atrial fibrillation and atrial flutter.
    Chiladakis JA, Kalogeropoulos A, Patsouras N, Manolis AS.
    J Am Coll Cardiol; 2004 Aug 18; 44(4):859-63. PubMed ID: 15312872
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.